Stocks
Denali Therapeutics (DNLI) P/E US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| P/E | ? | -18.7 | 0.00 | 0.00 | -7.93 | -5.65 | -7.05 | |
| Changes by years, y/y, % | -115% | -100% | -29% | |||||
Denali Therapeutics. P/E
Denali Therapeutics. P/E, changes, %
Denali Therapeutics (DNLI) P/E US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/E | ? | -5.01 | -5.02 | -5.65 | -7.05 | -9.42 | -7.05 | |
| Changes by years, y/y, % | -57% | -31% | +38% | +88% | ||||
| Changes by quarters, q/q, % | -2% | +0% | +13% | +25% | +34% | |||
